Table of Contents — November 01, 2024, 65 (11) | Journal of …
Nov 1, 2024 · Efficacy and Toxicity of [177 Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
Best Patient Care Practices for Administering PSMA-Targeted ...
Nov 1, 2024 · BEST PRACTICES FOR AE MANAGEMENT. The safety of [177 Lu]Lu-PSMA-617 in patients with mCRPC has been established in the phase III VISION study (3,7) and the phase II studies TheraP and RESIST-PC (8,9).In the VISION study, the most commonly reported AEs with [177 Lu]Lu-PSMA-617 treatment were fatigue, dry mouth, nausea, and anemia (Supplemental Table 1; supplemental materials are available at ...
Prostate Cancer Molecular Imaging Standardized Evaluation …
Mar 1, 2018 · Prostate-specific membrane antigen (PSMA)–ligand PET imaging provides unprecedented accuracy for whole-body staging of prostate cancer. As PSMA-ligand PET/CT is increasingly adopted in clinical trials and routine practice worldwide, a unified language for image reporting is urgently needed. We propose a molecular imaging TNM system (miTNM, version 1.0) as a standardized reporting framework ...
U.S. Imaging Costs | Journal of Nuclear Medicine
Nov 1, 2024 · Michal Horný, PhD, MSc, a health services researcher and assistant professor of Health Policy and Management at the University of Massachusetts Amherst, talked with Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School of Medicine at the UCLA, about a …
Diagnostic Radiopharmaceuticals: A Sustainable Path to the …
Oct 10, 2024 · Diagnostic radiopharmaceuticals are used in nuclear medicine scans to help physicians diagnose disease, assess treatment response, and determine eligibility for treatments. This article focuses on discussing the recent changes proposed by the Center for Medicare and Medicaid Services (CMS) in
Evaluation of Early-Stage Parkinson’s Disease with
Sep 1, 2001 · Significant differences in specific striatal uptake were found among healthy volunteers, patients with stage I disease, and patients with stage II disease (1.98 ± 0.24, 1.62 ± 0.11, and 1.22 ± 0.12, respectively, P < 0.01), as shown in Table 1 and Figure 2.Greater loss of uptake occurred in the putamen than in the caudate nucleus and contralateral to the more affected limbs, although ...
Hepatobiliary Scintigraphy in Evaluation of Sphincter of Oddi ...
1454 Introduction: Sphincter of Oddi dysfunction (SOD) refers to a functional obstruction of the sphincter of Oddi leading to hepatobiliary-type pain. Historically, the gold standard for diagnosis of SOD has been the detection of elevated sphincter pressure via manometry; however, this is an invasive procedure that carries with it a substantial risk of inducing pancreatitis.
A Noninvasive Test of Sphincter of Oddi Dysfunction in ...
Jun 1, 1992 · The ideal noninvasive test of sphincter of Oddi dysfunction (SOD) does not exist and the diagnosis of patients with postcholecystectomy pain often relies on invasive procedures. In this paper we describe a scintigraphic test for SOD: the scintigraphic score. This score combines quantitative and visual criteria for interpretation of hepatobiliary scans.
Volume 65 Number 11 October 2024 EDITOR'S PAGE 1661 The Costs to Our Patients MichaelG.Stabin DISCUSSIONS WITH LEADERS 1663 U.S. Imaging Costs MichalHorny,KenHerrmann,andJohannesCzernin THE STATE OF THE ART
JNM Copyright information | Journal of Nuclear Medicine
All manuscripts submitted to The Journal of Nuclear Medicine should be accompanied by a copyright disclosure statement in compliance with the Copyright Revision Act ...